Talazoparib for HER2-negative locally advanced or metastatic breast cancer with germline BRCA1/2-mutations [ID1342]: A Single Technology Appraisal

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bresnahan, Rebecca ORCID: 0000-0001-5578-1535, Mahon, james, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie, Boland, Angela, Dundar, Yenal, Marsden, Ashley, Malik, Zafar and Palmieri, Carlo (2024) Talazoparib for HER2-negative locally advanced or metastatic breast cancer with germline BRCA1/2-mutations [ID1342]: A Single Technology Appraisal [Report]

Access the full-text of this item by clicking on the Open Access link.

Item Type:	Report
Divisions:	Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Population Health Faculty of Health & Life Sciences > Inst. Population Health > Health Data Science
Depositing User:	Symplectic Admin
Date Deposited:	13 Nov 2025 10:59
Last Modified:	13 Nov 2025 10:59
Open Access URL:	https://www.nice.org.uk/guidance/ta952/evidence/dr...
Related Websites:	Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3195357
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.